Vimarsana
Biggest News Aggregation in the World

Page 3 - Aldx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aldx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aldx Today - Breaking & Trending Today

Aldeyra Therapeutics (NASDAQ:ALDX) Coverage Initiated at StockNews.com - Vimarsana News

Aldeyra Therapeutics (NASDAQ:ALDX) Coverage Initiated at StockNews.com

StockNews.com began coverage on shares of Aldeyra Therapeutics (NASDAQ:ALDX – Free Report) in a report released on Thursday. The brokerage issued a sell rating on the biotechnology company’s stock. Other equities research analysts have also issued reports about the company. Oppenheimer reissued an outperform rating and issued a $14.00 price target on shares of Aldeyra […]

Source: wkrb13.com
Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Sees Large Growth in Short Interest - Vimarsana News

Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Sees Large Growth in Short Interest

Aldeyra Therapeutics, Inc (NASDAQ:ALDX – Get Free Report) was the recipient of a significant growth in short interest in September. As of September 15th, there was short interest totalling 6,450,000 shares, a growth of 5.9% from the August 31st total of 6,090,000 shares. Based on an average trading volume of 646,300 shares, the short-interest ratio […]

Aldeyra Therapeutics (NASDAQ:ALDX) Stock Price Passes Below 50-Day Moving Average of $7.42 - Vimarsana News

Aldeyra Therapeutics (NASDAQ:ALDX) Stock Price Passes Below 50-Day Moving Average of $7.42

Shares of Aldeyra Therapeutics, Inc (NASDAQ:ALDX – Get Free Report) passed below its 50 day moving average during trading on Monday . The stock has a 50 day moving average of $7.42 and traded as low as $5.95. Aldeyra Therapeutics shares last traded at $6.15, with a volume of 583,139 shares traded. Analyst Ratings Changes […]

Aldeyra Therapeutics (NASDAQ:ALDX) Cut to "Sell" at StockNews.com - Vimarsana News

Aldeyra Therapeutics (NASDAQ:ALDX) Cut to "Sell" at StockNews.com

StockNews.com lowered shares of Aldeyra Therapeutics (NASDAQ:ALDX – Free Report) from a hold rating to a sell rating in a report issued on Sunday. A number of other research firms have also commented on ALDX. Oppenheimer reaffirmed an outperform rating and issued a $14.00 price objective on shares of Aldeyra Therapeutics in a research note […]

Source: wkrb13.com
Aldeyra Therapeutics (NASDAQ:ALDX) Downgraded by StockNews.com to "Sell" - Vimarsana News

Aldeyra Therapeutics (NASDAQ:ALDX) Downgraded by StockNews.com to "Sell"

StockNews.com cut shares of Aldeyra Therapeutics (NASDAQ:ALDX – Free Report) from a hold rating to a sell rating in a report released on Sunday morning. Other analysts also recently issued research reports about the company. HC Wainwright reissued a buy rating and issued a $15.00 price objective on shares of Aldeyra Therapeutics in a research […]